One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Strategies and End Points in the Development of Novel Immunotherapy Trials for Patients With Unresectable, Locally Advanced Non-Small-Cell Lung Cancer.
Pennell, Nathan A. MD, PhD 1,
doi : 10.1200/JCO.22.00827
Volume 40(29) pgs. 3353-3469 October 10, 2022
Untreated Chronic Hepatitis B Is Associated With a Higher Risk of Extrahepatic Malignancies.
Roberts, Lewis R. MBChB, PhD 1,
doi : 10.1200/JCO.22.01051
Impact of RxPONDER and monarchE on the Surgical Management of the Axilla in Patients With Breast Cancer.
Mittendorf, Elizabeth A. MD, PhD 1,2,; King, Tari A. MD 1,2; Tolaney, Sara M. MD, MPH 2,3
doi : 10.1200/JCO.22.00173
Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.
Rugo, Hope S. MD 1,; Bardia, Aditya MD, MPH 2,; Marme, Frederik MD, PhD 3,; Cortes, Javier MD, PhD 4,5,; Schmid, Peter MD, PhD 6,; Loirat, Delphine MD, PhD 7,; Tredan, Olivier MD, PhD 8,; Ciruelos, Eva MD, PhD 9,; Dalenc, Florence MD, PhD 10; Pardo, Patricia Gomez MD 11; Jhaveri, Komal L. MD 12,; Delaney, Rosemary MPH 13,; Fu, Olivia MD 14,; Lin, Lanjia PhD 15,; Verret, Wendy PhD 13,; Tolaney, Sara M. MD, MPH 16,; on behalf of the TROPiCS-02 Study Investigators
doi : 10.1200/JCO.22.01002
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.
Deek, Matthew P. MD 1,2; Van der Eecken, Kim MD, PhD 3; Sutera, Philip MD 2; Deek, Rebecca A. MS 4; Fonteyne, Valerie MD, PhD 5; Mendes, Adrianna A. MD 6; Decaestecker, Karel MD, PhD 7; Kiess, Ana Ponce MD, PhD 2; Lumen, Nicolaas MD, PhD 5; Phillips, Ryan MD, PhD 8; De Bruycker, Aurelie MD 7; Mishra, Mark MD 9; Rana, Zaker MD 9; Molitoris, Jason MD, PhD 9; Lambert, Bieke MD 10; Delrue, Louke MD 11; Wang, Hailun PhD 2; Lowe, Kathryn BS 2; Verbeke, Sofie MD, PhD 12; Van Dorpe, Jo MD, PhD 12; Bultijnck, Renee PhD 7; Villeirs, Geert MD 10; De Man, Kathia MD 13; Ameye, Filip MD 14; Song, Daniel Y. MD 2; DeWeese, Theodore MD 2; Paller, Channing J. MD 15; Feng, Felix Y. MD 16; Wyatt, Alexander PhD 17; Pienta, Kenneth J. MD 15,18; Diehn, Maximillian MD, PhD 19; Bentzen, Soren M. PhD, DMsc 9,20; Joniau, Steven MD, PhD 21; Vanhaverbeke, Friedl MD 22; De Meerleer, Gert MD 23; Antonarakis, Emmanuel S. MD 24; Lotan, Tamara L. MD 6; Berlin, Alejandro MD 25; Siva, Shankar MD, PhD 26; Ost, Piet MD, PhD 27,28; Tran, Phuoc T. MD, PhD 2,9,15,18,
doi : 10.1200/JCO.22.00644
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer.
Herbst, Roy S. MD, PhD 1,; Majem, Margarita MD, PhD 2; Barlesi, Fabrice MD, PhD 3; Carcereny, Enric MD 4; Chu, Quincy MD 5; Monnet, Isabelle MD, PhD 6; Sanchez-Hernandez, Alfredo MD 7; Dakhil, Shaker MD 8; Camidge, D. Ross MD, PhD 9; Winzer, Leanne MSc 10; Soo-Hoo, Yee MPH 11; Cooper, Zachary A. PhD 11; Kumar, Rakesh MD, PhD 11; Bothos, John PhD 11; Aggarwal, Charu MD, MPH 12; Martinez-Marti, Alex MD 13
doi : 10.1200/JCO.22.00227
Association of Chronic Hepatitis B Infection and Antiviral Treatment With the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study.
Lee, Dong Hyeon MD 1,2; Chung, Sung Won MD 1; Lee, Jeong-Hoon MD, PhD 1,; Kim, Hwi Young MD, PhD 3; Chung, Goh Eun MD, PhD 4; Kim, Mi-Sook MD, PhD 5; Yang, Bo Ram PhD 5,6; Nam, Joon Yeul MD 1; Lee, Yun Bin MD, PhD 1; Kim, Yoon Jun MD, PhD 1; Yoon, Jung-Hwan MD, PhD 1
doi : 10.1200/JCO.21.01285
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
D'Agostino, Mattia MD 1,; Cairns, David A. PhD 2; Lahuerta, Juan Jose MD, PhD 3; Wester, Ruth MD 4; Bertsch, Uta MD 5; Waage, Anders MD, PhD 6; Zamagni, Elena MD, PhD 7,8; Mateos, Maria-Victoria MD, PhD 9; Dall'Olio, Daniele MSc 10; van de Donk, Niels W.C.J. MD, PhD 11; Jackson, Graham MD 12; Rocchi, Serena MD 7,8; Salwender, Hans MD 13; Blade Creixenti, Joan MD, PhD 14; van der Holt, Bronno PhD 15; Castellani, Gastone PhD 8; Bonello, Francesca MD 1; Capra, Andrea MScEng 1; Mai, Elias K. MD 5; Durig, Jan MD 16; Gay, Francesca MD, PhD 1; Zweegman, Sonja MD, PhD 11; Cavo, Michele MD 7,8; Kaiser, Martin F. MD 17; Goldschmidt, Hartmut MD 5; Hernandez Rivas, Jesus Maria MD, PhD 18; Larocca, Alessandra MD, PhD 1; Cook, Gordon MD, PhD 2; San-Miguel, Jesus F. MD, PhD 19; Boccadoro, Mario MD 1; Sonneveld, Pieter MD, PhD 4
doi : 10.1200/JCO.21.02614
Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial.
Yoshino, Takayuki MD, PhD 1,; Oki, Eiji MD, PhD 2; Misumi, Toshihiro PhD 3; Kotaka, Masahito MD, PhD 4; Manaka, Dai MD, PhD 5; Eto, Tetsuya MD 6; Hasegawa, Junichi MD, PhD 7; Takagane, Akinori MD, PhD 8; Nakamura, Masato MD, PhD 9; Kato, Takeshi MD, PhD 10; Munemoto, Yoshinori MD, PhD 11; Nakamura, Fumitaka MD, PhD 12; Bando, Hiroyuki MD, PhD 13; Taniguchi, Hiroki MD, PhD 14; Sakamoto, Yasuhiro MD, PhD 15; Shiozawa, Manabu MD, PhD 16; Nishi, Masayasu MD, PhD 17; Horiuchi, Tetsuya MD, PhD 18; Yamagishi, Hisakazu MD, PhD 19; Sakamoto, Junichi MD, PhD 19; Mizushima, Tsunekazu MD, PhD 20; Ohtsu, Atsushi MD, PhD 21; Mori, Masaki MD, PhD 22
doi : 10.1200/JCO.21.02628
Incidence of Cardiovascular Events in Patients Treated With Immune Checkpoint Inhibitors.
Laenens, Dorien MD 1,; Yu, Yuling MD 2; Santens, Beatrice MD 3; Jacobs, Johanna MD 3; Beuselinck, Benoit MD, PhD 4; Bechter, Oliver MD, PhD 4; Wauters, Els MD; PhD 5; Staessen, Jan MD, PhD 6,7; Janssens, Stefan MD, PhD 1,3; Van Aelst, Lucas MD, PhD 1,3
doi : 10.1200/JCO.21.01808
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program.
Naqash, Abdul Rafeh MD 1,2; Moey, Melissa Y.Y. MD, MSc 3; Cherie Tan, Xiao-Wei MD 4; Laharwal, Mehak MD 5; Hill, Vanessa 6; Moka, Nagabhishek MD 7; Finnigan, Shanda MPH 8; Murray, James PhD 9; Johnson, Douglas B. MD 10; Moslehi, Javid J. MD 11; Sharon, Elad MD, MPH 1,
doi : 10.1200/JCO.22.00369
Minus Times Minus Equals Plus.
Haanen, John B.A.G. PhD, MD 1,; Peters, Solange PhD, MD 2
doi : 10.1200/JCO.22.01112
The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions.
De Wilde, Bram MD 1,2; Barry, Elly MD 3,; Fox, Elizabeth MD 4; Karres, Dominik MD 5; Kieran, Mark MD 3,; Manlay, John BA 6,; Ludwinski, Donna BSChE 7,; Reaman, Gregory MD 8; Kearns, Pamela MBChB, PhD 9,
doi : 10.1200/JCO.22.00033
Reply to P. Petranovic Ovcaricek et al.
Pasqual, Elisa PhD; Schonfeld, Sara PhD; Morton, Lindsay M. PhD; Villoing, Daphnee PhD; Lee, Choonsik PhD; Berrington de Gonzalez, Amy PhD; Kitahara, Cari M. PhD
doi : 10.1200/JCO.22.00735
Reply to P. Petranovic Ovcaricek et al.
McDonald, Andrew M. MD, MS; Galgano, Samuel J. MD
doi : 10.1200/JCO.22.00753
Atherosclerotic Cardiovascular Risk With Combination Avelumab and Axitinib.
Tan, Sean MBBS; Day, Daphne MBBS; Nicholls, Stephen J. MBBS, PhD; Segelov, Eva MBBS, PhD
doi : 10.1200/JCO.22.00712
Reply to S. Tan et al.
Rini, Brian I. MD; Moslehi, Javid J. MD; Hariharan, Subramanian MD
doi : 10.1200/JCO.22.01108
